☆ 4.7 Letter

Factors Associated With Weight Gain in People With Type 2 Diabetes Starting on Insulin. Diabetes Care 2014;37:2108-2113

DIABETES CARE (2014)

Journal

DIABETES CARE

Volume 37, Issue 12, Pages E265-E265

Publisher

AMER DIABETES ASSOC

DOI: 10.2337/dc14-1916

Keywords

-

Categories

Endocrinology & Metabolism

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

Review Endocrinology & Metabolism

Obesity in people living with type 1 diabetes

Bart Van der Schueren, Darcy Ellis, Raquel N. Faradji, Eeba Al-Ozairi, Jonathan Rosen, Chantal Mathieu

Summary: Although traditionally considered a disease of lean individuals, overweight and obesity are becoming more common in people with type 1 diabetes, leading to increased risk of diabetes-related and obesity-related complications such as cardiovascular disease, stroke, and cancer. Preventing and treating excessive bodyweight in people with type 1 diabetes is crucial to optimizing their health outcomes.

LANCET DIABETES & ENDOCRINOLOGY (2021)

Add to Collection

Article Medicine, General & Internal

Association of Habitual Alcohol Consumption With Long-term Risk of Type 2 Diabetes Among Women With a History of Gestational Diabetes

Stefanie N. Hinkle, Wei Bao, Jing Wu, Yangbo Sun, Sylvia H. Ley, Deirdre K. Tobias, Frank Qian, Shristi Rawal, Yeyi Zhu, Jorge E. Chavarro, Frank B. Hu, Cuilin Zhang

Summary: In women with a history of gestational diabetes, moderate alcohol intake of 5.0 to 14.9 g/d (approximately 0.5-1 drinks per day) was associated with a lower risk for type 2 diabetes. However, there was no significant association between low intake (0.1-4.9 g/d) or high intake (15.0 g/d or more) of alcohol and risk of type 2 diabetes.

JAMA NETWORK OPEN (2021)

Add to Collection

Article Obstetrics & Gynecology

The effects of insulin therapy on maternal blood pressure and weight in women with gestational diabetes mellitus

Tiange Sun, Fanhua Meng, Shufei Zang, Yue Li, Rui Zhang, Zhiyan Yu, Xinmei Huang, Fang Wang, Liwen Zhang, Jun Liu

Summary: This study found that insulin therapy for women with gestational diabetes was associated with a slight increase in maternal weight but a significant risk of increasing maternal blood pressure.

BMC PREGNANCY AND CHILDBIRTH (2021)

Add to Collection

Article Endocrinology & Metabolism

Role of Excessive Weight Gain During Gestation in the Risk of ADHD in Offspring of Women With Gestational Diabetes

Veronica Perea, Andreu Simo-Servat, Carmen Quiros, Nuria Alonso-Carril, Maite Valverde, Xavier Urquizu, Antonio J. Amor, Eva Lopez, Maria-Jose Barahona

Summary: This study found that pregestational obesity is associated with a higher risk of ADHD in offspring of GDM pregnancies. However, excessive weight gain during pregnancy does not have an independent effect on ADHD risk. Only the joint association of obesity and excessive weight gain during pregnancy remains significant in relation to ADHD risk.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2022)

Add to Collection

Article Medicine, Research & Experimental

Metformin action over gut microbiota is related to weight and glycemic control in gestational diabetes mellitus: A randomized trial

Maria Molina-Vega, Maria J. Picon-Cesar, Carolina Gutierrez-Repiso, Andrea Fernandez-Valero, Fuensanta Lima-Rubio, Stella Gonzalez-Romero, Isabel Moreno-Indias, Francisco J. Tinahones

Summary: In women with gestational diabetes mellitus, treatment with metformin led to lower postprandial glycemia and less weight gain compared to treatment with insulin. There were also changes in the composition of gut microbiota, with a decrease in Firmicutes and Peptostreptococcaceae abundance and an increase in Proteobacteria and Enterobacteriaceae abundance in the metformin group. Predicted metabolic pathways related to propionate degradation and ubiquinol biosynthesis were more prevalent in the metformin group. Further studies are needed to understand how these changes impact metabolic control during and after pregnancy.

BIOMEDICINE & PHARMACOTHERAPY (2022)

Add to Collection

Article Endocrinology & Metabolism

Glycaemic Control in People with Diabetes Starting Treatment with Fast-Acting Insulin Aspart: a US Database Study

Wendy Lane, Mads Faurby, Lise Lotte N. Husemoen, Dmitriy L. Markovich, Naveen Rathor, Christophe De Block

Summary: The study found that there was a significant improvement in HbA1c levels after 6 months of initiating faster aspart treatment for individuals with type 2 diabetes in a real-world setting. However, there was no significant improvement for individuals with type 1 diabetes overall. Regardless of diabetes type, patients with higher baseline HbA1c levels showed significant reductions in HbA1c.

DIABETES THERAPY (2021)

Add to Collection

Article Immunology

Weight Change Following Antiretroviral Therapy Switch in People With Viral Suppression: Pooled Data from Randomized Clinical Trials

Kristine M. Erlandson, Christoph C. Carter, Kathleen Melbourne, Todd T. Brown, Cal Cohen, Moupali Das, Stefan Esser, Hailin Huang, John R. Koethe, Hal Martin, Grace A. McComsey, Chloe Orkin, Frank A. Post, Juergen K. Rockstroh, Paul E. Sax, Hans-Juergen Stellbrink, Laura Waters, Xuelian Wei, Jordan E. Lake

Summary: A pooled analysis of 12 prospective clinical trials found that moderate weight gain was common after ART switch in people living with HIV, with participants who switched off of efavirenz and tenofovir having the greatest weight gain. Further study is needed to understand the biological mechanisms behind these differential effects and their clinical implications.

CLINICAL INFECTIOUS DISEASES (2021)

Add to Collection

Article Endocrinology & Metabolism

The physiological basis of insulin therapy in people with diabetes mellitus

Geremia B. Bolli, Francesca Porcellati, Paola Lucidi, Carmine G. Fanelli

Summary: The development of insulin therapy indicates the importance of mimicking the physiological process of pancreatic insulin secretion in treating diabetes. Replacing insulin through a basal-bolus mode effectively controls blood sugar levels in diabetic patients, prevents complications, and ensures quality of life.

DIABETES RESEARCH AND CLINICAL PRACTICE (2021)

Add to Collection

Review Pharmacology & Pharmacy

The effect of insulin analogs in people with type 1 diabetes at increased risk of severe hypoglycemia

Sofie Broeng-Mikkelgaard, Julie Maria Boggild Brosen, Peter Lommer Kristensen, Birger Thorsteinsson, Ulrik Pedersen-Bjergaard

Summary: Insulin therapy has evolved and new insulin analogs have been developed, but hypoglycemia remains a major side effect. Current insulin trials often exclude high-risk individuals, underestimating the clinical impact and pharmacoeconomic effect of new insulins. New research shows that high-risk individuals have better treatment outcomes in reducing hypoglycemia.

FRONTIERS IN PHARMACOLOGY (2023)

Add to Collection

Article Infectious Diseases

Energy balance and body composition after switch between integrase strand transfer inhibitors and doravirine among people with HIV

Kristine M. Erlandson, Ruda Mohaweche, Mary Morrow, Samantha Mawhinney, Vincent Khuu, Mallory Boyd, Ashok Balasubramanyam, Edward L. Melanson, Jordan E. Lake

Summary: This study found that switching to doravirine treatment may be associated with reductions in 24-hour energy expenditure, weight, trunk fat, and fat-free mass among HIV patients with over 10% weight gain.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2023)

Add to Collection

Article Medicine, General & Internal

LY3437943, a novel triple GIP, GLP-1, and glucagon receptor agonist in people with type 2 diabetes: a phase 1b, multicentre, double-blind, placebo-controlled, randomised, multiple-ascending dose trial

Shweta Urva, Tamer Coskun, Mei Teng Loh, Yu Du, Melissa K. Thomas, Sirel Gurbuz, Axel Haupt, Charles T. Benson, Martha Hernandez-Illas, David A. D'Alessio, Zvonko Milicevic

Summary: LY3437943, a multi-receptor agonist for the treatment of type 2 diabetes and obesity, demonstrated acceptable safety, suitable pharmacokinetics for once-weekly dosing, and significant improvements in glucose and bodyweight outcomes in this study.

LANCET (2022)

Add to Collection

Article Endocrinology & Metabolism

Living with Insulin: The story of insulin from people with diabetes

Paolo Di Bartolo, Robert H. Eckel

Summary: The history of insulin is considered one of the most beautiful stories in medicine, with significant achievements and acceleration of treatment opportunities in the last 50 years. Innovations in insulin therapy in recent decades have greatly impacted the quality of life for diabetes patients, allowing for a more personalized and adaptable approach to treatment.

DIABETES RESEARCH AND CLINICAL PRACTICE (2021)

Add to Collection

Article Endocrinology & Metabolism

Low Gestational Weight Gain in Women With Gestational Diabetes Is Safe With Better Metabolic Profile Postpartum

Caro Minschart, Astrid Lammertyn, Paul Van Crombrugge, Carolien Moyson, Johan Verhaeghe, Sofie Vandeginste, Hilde Verlaenen, Chris Vercammen, Toon Maes, Els Dufraimont, Nele Roggen, Christophe De Block, Yves Jacquemyn, Farah Mekahli, Katrien De Clippel, Annick Van Den Bruel, Anne Loccufier, Annouschka Laenen, Roland Devlieger, Chantal Mathieu, Katrien Benhalima

Summary: The level of gestational weight gain (GWG) during pregnancy is associated with adverse pregnancy outcomes in women with gestational diabetes (GDM) compared to women with normal glucose tolerance (NGT). Low GWG below recommended levels frequently occurs in GDM women without increased risk for adverse outcomes. Excessive GWG is associated with increased risk for neonatal hypoglycemia and worse metabolic profile postpartum in GDM women, and with higher rates of instrumental delivery and larger infants in NGT women.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2023)

Add to Collection

Article Medicine, General & Internal

Comparison of Rates of Type 2 Diabetes in Adults and Children Treated With Anticonvulsant Mood Stabilizers

Jenny W. Sun, Jessica G. Young, Aaron L. Sarvet, L. Charles Bailey, William J. Heerman, David M. Janicke, Pi-I Debby Lin, Sengwee Toh, Jason P. Block

Summary: In this cohort study, the use of valproate in adults was associated with the highest risk of developing type 2 diabetes (T2D). The comparative safety of anticonvulsant mood stabilizers was generally similar in children, but the estimates were small and variable. Emulating target trials within health care databases can provide important age-specific drug safety data for decision-making.

JAMA NETWORK OPEN (2022)

Add to Collection

Article Medicine, Research & Experimental

Aetiology of Type 2 diabetes in people with a 'normal' body mass index: testing the personal fat threshold hypothesis

Roy Taylor, Alison C. Barnes, Kieren G. Hollingsworth, Keaton M. Irvine, Alexandra S. Solovyova, Lucy Clark, Tara Kelly, Carmen Martin-Ruiz, Davide Romeres, Albert Koulman, Claire M. Meek, Benjamin Jenkins, Claudio Cobelli, Rury R. Holman

Summary: Weight loss in overweight or obese individuals with Type 2 diabetes can normalize hepatic fat metabolism, improve insulin secretion, and control blood glucose levels. The Personal Fat Threshold hypothesis suggests that different individuals have varying thresholds for the adverse effects of excess fat on beta-cell function. Through weight loss, beta-cell function and blood glucose levels can be restored, leading to sustained diabetes remission.

CLINICAL SCIENCE (2023)

Add to Collection

Article Peripheral Vascular Disease

Obesity and cardiovascular risk: a call for action from the European Society of Hypertension Working Group of Obesity, Diabetes and the High-risk Patient and European Association for the Study of Obesity: part B: obesity-induced cardiovascular disease, early prevention strategies and future research directions

Vasilios Kotsis, Konstantinos Tsioufis, Christina Antza, Gino Seravalle, Antonio Coca, Cristina Sierra, Empar Lurbe, Stella Stabouli, Bojan Jelakovic, Josep Redon, Pau Redon, Peter M. Nilsson, Jens Jordan, Dragan Micic, Nicholas Finer, Deborah R. Leitner, Hermann Toplak, Lale Tokgozoglu, Vasilios Athyros, Moses Elisaf, Theodosios D. Filippatos, Guido Grassi

JOURNAL OF HYPERTENSION (2018)

Add to Collection

Article Peripheral Vascular Disease

Obesity and cardiovascular risk: a call for action from the European Society of Hypertension Working Group of Obesity, Diabetes and the High-risk Patient and European Association for the Study of Obesity: part A: mechanisms of obesity induced hypertension, diabetes and dyslipidemia and practice guidelines for treatment

Vasilios Kotsis, Jens Jordan, Dragan Micic, Nicholas Finer, Deborah R. Leitner, Hermann Toplak, Lale Tokgozoglu, Vasilios Athyros, Moses Elisaf, Theodosios D. Filippatos, Josep Redon, Pau Redon, Christina Antza, Konstantinos Tsioufis, Guido Grassi, Gino Seravalle, Antonio Coca, Cristina Sierra, Empar Lurbe, Stella Stabouli, Bojan Jelakovic, Peter M. Nilsson

JOURNAL OF HYPERTENSION (2018)

Add to Collection

Article Cardiac & Cardiovascular Systems

Early vascular damage from smoking and alcohol in teenage years: the ALSPAC study

Marietta Charakida, George Georgiopoulos, Frida Dangardt, Scott T. Chiesa, Alun D. Hughes, Alicja Rapala, George Davey Smith, Debbie Lawlor, Nicholas Finer, John E. Deanfield

EUROPEAN HEART JOURNAL (2019)

Add to Collection

Article Cardiac & Cardiovascular Systems

Assessing the Causal Role of Body Mass Index on Cardiovascular Health in Young Adults Mendelian Randomization and Recall-by-Genotype Analyses

Kaitlin H. Wade, Scott T. Chiesa, Alun D. Hughes, Nish Chaturvedi, Marietta Charakida, Alicja Rapala, Vivek Muthurangu, Tauseef Khan, Nicholas Finer, Naveed Sattar, Laura D. Howe, Abigail Fraser, Debbie A. Lawlor, George Davey Smith, John E. Deanfield, Nicholas J. Timpson

CIRCULATION (2018)

Add to Collection

Letter Surgery

Letter to the Editor regarding Mocanu et al. Ongoing Inconsistencies in Weight Loss Reporting Following Bariatric Surgery: a Systematic Review. Obesity Surgery https://doi.org/10.1007/s11695-018-03702-6Mocanu

Nick Finer

OBESITY SURGERY (2019)

Add to Collection

Editorial Material Cardiac & Cardiovascular Systems

Weight loss for patients with obesity and heart failure

Nicholas Finer

EUROPEAN HEART JOURNAL (2019)

Add to Collection

Editorial Material Cardiac & Cardiovascular Systems

Response to 'Does smoking or alcohol cause early vascular damage in teenage years?'

Marietta Charakida, Georgios Georgiopoulos, Frida Dangardt, Scott T. Chiesa, Alun D. Hughes, Alicia Rapala, George Davey Smith, Deborah Lawlor, Nicholas Finer, John E. Deanfield

EUROPEAN HEART JOURNAL (2019)

Add to Collection

Article Endocrinology & Metabolism

Weight loss interventions and nonalcoholic fatty liver disease: Optimizing liver outcomes

Nick Finer

Summary: The increase in prevalence of obesity, type 2 diabetes, and nonalcoholic fatty liver disease (NAFLD) presents a significant global health challenge. Weight loss has been identified as the most effective treatment for NAFLD, improving biomarkers, preventing progression, and sometimes reversing fibrosis. Pharmacotherapy, either alone or in combination with lifestyle interventions, is bridging the efficacy gap between diet and exercise and weight-loss surgery in reversing obesity.

DIABETES OBESITY & METABOLISM (2022)

Add to Collection

Article Medicine, General & Internal

Future directions in obesity pharmacotherapy

Nick Finer

Summary: There is a growing need for more effective treatment of obesity and its complications, with current medications falling short of the efficacy seen with bariatric surgery. Gut peptide analogues are leading the way in clinical development and are likely to meet regulatory requirements soon. Early-stage drug development targeting different energy balance pathways may lead to more complex and personalized treatment guidelines.

EUROPEAN JOURNAL OF INTERNAL MEDICINE (2021)

Add to Collection

Editorial Material Endocrinology & Metabolism

A new Editor-in-Chief

Nick Finer

CLINICAL OBESITY (2022)

Add to Collection

Article Pharmacology & Pharmacy

Prevalence of Baseline Cardiac Arrhythmias in Participants with Overweight or Obesity in Phase 1 Clinical Trials: Analysis of 24-Hour Holter Electrocardiogram Recordings

Dorthe Skovgaard, Poul-Martin Haahr, Robert Lester, Katherine Clark, Sabina Paglialunga, Nick Finer, Martin H. H. Friedrichsen, Julie B. B. Hjerpsted, Mads D. M. Engelmann

Summary: Although prevalence of cardiac arrhythmias in healthy volunteers has been estimated, there is limited baseline data for populations such as overweight and obese individuals, who are increasingly participating in clinical trials. This study examined the baseline prevalence of arrhythmias in overweight or obese participants in two phase 1 trials of weight management medications. The findings showed that most arrhythmias were rare, and the prevalence mirrored that of healthy participants with normal weight. Knowledge of the baseline prevalence of arrhythmias in overweight and obese individuals can inform trial eligibility criteria and improve decision-making in weight management clinical trials.

JOURNAL OF CLINICAL PHARMACOLOGY (2023)

Add to Collection

Article Endocrinology & Metabolism

Body mass index trajectories among people with obesity and association with mortality: Evidence from a large Israeli database

Orna Reges, Dror Dicker, Christiane L. Haase, Nick Finer, Tomas Karpati, Morton Leibowitz, Altynai Satylganova, Becca Feldman

Summary: This study examined BMI trajectories over 5 years in a large population with obesity and found that individuals with stable high weight had the lowest mortality. These findings contribute to the scientific understanding of the impact of weight trajectories on health outcomes.

OBESITY SCIENCE & PRACTICE (2021)

Add to Collection

Article Health Policy & Services

A comprehensive descriptive assessment of obesity related chronic morbidity and estimated annual cost burden from a population-based electronic health record database

Orna Reges, Morton Leibowitz, Avital Hirsch, Dror Dicker, Nick Finer, Christiane Lundegaard Haase, Altynai Satylganova, Maya Leventer-Roberts, Becca Feldman

ISRAEL JOURNAL OF HEALTH POLICY RESEARCH (2020)

Add to Collection

Article Pediatrics

Association between fat mass through adolescence and arterial stiffness: a population-based study from The Avon Longitudinal Study of Parents and Children

Frida Dangardt, Marietta Charakida, Georgios Georgiopoulos, Scott T. Chiesa, Alicja Rapala, Kaitlin H. Wade, Alun D. Hughes, Nicholas J. Timpson, Konstantinos Pateras, Nick Finer, Naveed Sattar, George Davey Smith, Debbie A. Lawlor, John E. Deanfield

LANCET CHILD & ADOLESCENT HEALTH (2019)

Add to Collection

Article Endocrinology & Metabolism

Type 2 diabetes remission 2 years post Roux-en-Y gastric bypass and sleeve gastrectomy: the role of the weight loss and comparison of DiaRem and DiaBetter scores

A. Pucci, U. Tymoszuk, W. H. Cheung, J. M. Makaronidis, S. Scholes, G. Tharakan, M. Elkalaawy, M. Guimaraes, M. Nora, M. Hashemi, A. Jenkinson, M. Adamo, M. P. Monteiro, N. Finer, R. L. Batterham

DIABETIC MEDICINE (2018)

Add to Collection

No Data Available

© Peeref 2019-2024. All rights reserved.